The S&P 500 posted gains in May, June, and July, a rare occurrence that has historically preceded more upside in the next ...

Follow all the latest U.S. market action for Tuesday here to see if stocks can shake of some summer torpor and reach fresh ...

Nevada, Maryland, and North Carolina lead in year-over-year inventory growth, with Nevada experiencing a 52.9% increase, ...

Long gone are the days of unprofitable growth for Uber. On the bottom line, the company reported a net profit of $1.4 billion ...

The AI boom could be a $16 trillion gift to the stock market, but AI-driven value creation could mean tough times ahead for ...

The stock market is heading into a catalyst-filled week as Fed Chair Jerome Powell gets ready to speak at Jackson Hole and ...

While it may be hard to believe, the 2025 NFL preseason is already winding down. The final exhibition games will be played on ...

Nio ( NYSE: NIO) announced on Monday that it is planning further expansion. The Chinese electric vehicle maker plans to enter ...

That pundit initiated coverage of the stock with the equivalent of a buy recommendation. Happily for investors, that pundit ...

America’s obesity crisis extends beyond humans — studies suggest that around 60% of dogs and cats nationwide are overweight.

A company with a chatbot that often gets things wrong is somehow about to become the largest unicorn earth has ever seen.

Justin Zelin, BTIG senior biotech analyst, joins 'The Exchange' to discuss GLP-1's and the share decline for Viking Therapeutics and why he's still bullish the stock.